Parkinson's Disease clinical trials at UC Davis
1 research study open to eligible people
“Please consider this clinical research study evaluating the safety and efficacy of an investigational gene therapy in Parkinson's Disease”
open to eligible people ages 40-75
The objectives of this study are to assess the efficacy, safety and tolerability of VY-AADC02 in Patients with Parkinson's Disease with Motor Fluctuations.
Sacramento, California and other locations